| pubmed-article:1925260 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1925260 | lifeskim:mentions | umls-concept:C0003873 | lld:lifeskim |
| pubmed-article:1925260 | lifeskim:mentions | umls-concept:C0043407 | lld:lifeskim |
| pubmed-article:1925260 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:1925260 | lifeskim:mentions | umls-concept:C0205332 | lld:lifeskim |
| pubmed-article:1925260 | lifeskim:mentions | umls-concept:C0449445 | lld:lifeskim |
| pubmed-article:1925260 | lifeskim:mentions | umls-concept:C0021212 | lld:lifeskim |
| pubmed-article:1925260 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:1925260 | pubmed:dateCreated | 1991-11-19 | lld:pubmed |
| pubmed-article:1925260 | pubmed:abstractText | A total of 140 patients with reactive arthritis due to Yersinia infection were under observation for 2-10 years. A group of 104 patients with erosive rheumatoid arthritis served as control for analysis of the results of bacteriological and serological studies. The bacteriological analysis of the feces, urine, smears of the feces and blood were made repeatedly. As established the articular syndrome in reactive arthrosis has its specific features depending on the nature of the pathological process: primary, recurrent and chronic. Patients with primary reactive arthritis exhibited recovery without residual phenomena and relapses in 35.8% of the cases; in 86% the disease relapsed; in 36% it was chronic, persisting for a number of years as a non-erosive seronegative arthritis; in 25.3% arthralgia persisted; in 6.2% the clinical picture of secondary osteoarthrosis developed; in 17.3% the disease changed into spondyloarthritis and in 1.2% of the cases it changed into RA. Since in reactive arthritis Yersinia infection was confirmed in 48.5% of the cases and in RA in 14-21%, laboratory diagnosis cannot serve as an absolute criterion for reactive arthritis. It is necessary to take into consideration the anamnesis and the peculiarities of the clinical picture and the course of the articular syndrome. | lld:pubmed |
| pubmed-article:1925260 | pubmed:language | rus | lld:pubmed |
| pubmed-article:1925260 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1925260 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1925260 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1925260 | pubmed:issn | 0233-7029 | lld:pubmed |
| pubmed-article:1925260 | pubmed:author | pubmed-author:AgababovaE... | lld:pubmed |
| pubmed-article:1925260 | pubmed:author | pubmed-author:Sidel'nikovaS... | lld:pubmed |
| pubmed-article:1925260 | pubmed:author | pubmed-author:BorovikV ZVZ | lld:pubmed |
| pubmed-article:1925260 | pubmed:author | pubmed-author:IushchenkoG... | lld:pubmed |
| pubmed-article:1925260 | pubmed:author | pubmed-author:AseevaE MEM | lld:pubmed |
| pubmed-article:1925260 | pubmed:author | pubmed-author:RiazantsevaT... | lld:pubmed |
| pubmed-article:1925260 | pubmed:author | pubmed-author:ElkinaIu BIuB | lld:pubmed |
| pubmed-article:1925260 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1925260 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1925260 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1925260 | pubmed:pagination | 19-26 | lld:pubmed |
| pubmed-article:1925260 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:1925260 | pubmed:meshHeading | pubmed-meshheading:1925260-... | lld:pubmed |
| pubmed-article:1925260 | pubmed:meshHeading | pubmed-meshheading:1925260-... | lld:pubmed |
| pubmed-article:1925260 | pubmed:meshHeading | pubmed-meshheading:1925260-... | lld:pubmed |
| pubmed-article:1925260 | pubmed:meshHeading | pubmed-meshheading:1925260-... | lld:pubmed |
| pubmed-article:1925260 | pubmed:meshHeading | pubmed-meshheading:1925260-... | lld:pubmed |
| pubmed-article:1925260 | pubmed:meshHeading | pubmed-meshheading:1925260-... | lld:pubmed |
| pubmed-article:1925260 | pubmed:meshHeading | pubmed-meshheading:1925260-... | lld:pubmed |
| pubmed-article:1925260 | pubmed:meshHeading | pubmed-meshheading:1925260-... | lld:pubmed |
| pubmed-article:1925260 | pubmed:meshHeading | pubmed-meshheading:1925260-... | lld:pubmed |
| pubmed-article:1925260 | pubmed:meshHeading | pubmed-meshheading:1925260-... | lld:pubmed |
| pubmed-article:1925260 | pubmed:meshHeading | pubmed-meshheading:1925260-... | lld:pubmed |
| pubmed-article:1925260 | pubmed:meshHeading | pubmed-meshheading:1925260-... | lld:pubmed |
| pubmed-article:1925260 | pubmed:articleTitle | [Approach to evaluation of the indicators of Yersinia infections in reactive and rheumatoid arthritis]. | lld:pubmed |
| pubmed-article:1925260 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1925260 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:1925260 | pubmed:publicationType | English Abstract | lld:pubmed |
